Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression
Abstract
Despite intense research efforts undertaken by investigators throughout the world over the past half century to identify a specific biomarker for major depressive disorder (MDD), none have so far met the rigorous test of specificity, reliability and reproducibility. Vascular Endothelial Growth Factor (VEGF) has been implicated in the neurotrophic model of depression and several studies have assessed VEGF levels in depressed patients. The results have been discrepant largely due to design and assay differences among studies. The aim of this study was to assess plasma VEGF levels in a cohort of MDD subjects prior to treatment with psychotropic medication and compare them to those of healthy control (HC) subjects. Prospective study participants underwent extensive medical and psychiatric assessments before they were enrolled. Plasma concentrations of VEGF were measured by the technique marketed by Randox Technologies. The mean baseline VEGF for the healthy and depressed groups was 5.91 pg/ml (SD: 3.04) and 10.51 pg/ml (SD: 9.04), respectively, and this difference was statistically significant (p = 0.001). We detected a very low univariate relationship between VEGF and demographic and clinical variables. Using the Optimal Data Analysis a cut score of 6.64 pg/ml for baseline plasma VEGF distinguished depressed from healthy subjects with a 63% overall accuracy. We conclude these results support a role of plasma VEGF as a useful biomarker of depression that can be measured with a routine blood draw at the point of service. The specificity of this potential biomarker must be confirmed in studies that include other psychiatric disease entities.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
VEGF could be involved in the connection between COVID-19, major depressive disorder and purinergic signaling.
“Thus, although VEGF involvement in major depressive disorder is controversially discussed [169, 170], this growth factor could be involved in the connection between COVID-19, major depressive disorder and purinergic signaling.”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [169]
Cites
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Cohen, P., Cohen, P., West, S. G., & Aiken, L. S. (2014) · Psychology Press eBooks · doi:10.4324/9781410606266 · Cited by 20,819 · see citing works
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,988 · see citing works
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works
Vascular endothelial growth factor (VEGF) stimulates neurogenesis <i>in vitro</i> and <i>in vivo</i>
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507 · see citing works
VEGF links hippocampal activity with neurogenesis, learning and memory
Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., & During, M. J. (2004) · Nature Genetics · doi:10.1038/ng1395 · Cited by 850 · see citing works
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
Storkebaum, E., Lambrechts, D., & Carmeliet, P. (2004) · BioEssays · doi:10.1002/bies.20092 · Cited by 505 · see citing works
Boldrini, M., Hen, R., Underwood, M. D., Rosoklija, G. B., Dwork, A. J., Mann, J. J., & Arango, V. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.024 · Cited by 348 · see citing works
Heine, V. M., Zareno, J., Maslam, S., Joëls, M., & Lucassen, P. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03951.x · Cited by 225 · see citing works
Optimal Data Analysis: A Guidebook with Software for Windows
Yarnold, P. R., & Soltysik, R. C. (2004) · Cited by 131 · see citing works
McCloskey, D. P., Croll, S. D., & Scharfman, H. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2577-05.2005 · Cited by 121 · see citing works
Kahl, K. G., Bens, S., Ziegler, K. J., Rudolf, S., Kordon, A., DIBBELT, L., & Schweiger, U. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.016 · Cited by 112 · see citing works
VEGF and depression: A comprehensive assessment of clinical data
Clark-Raymond, A., & Halaris, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.04.008 · Cited by 108 · see citing works
Self-citationIga, J., Ueno, S., Yamauchi, K., Numata, S., Shibuya‐Tayoshi, S., Kinouchi, S., Nakataki, M., Song, H., Hokoishi, K., Tanabe, H., et al. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.011 · Cited by 105 · see citing works
Döme, P., Teleki, Z., Ríhmer, Z., Peter, L., Dobos, J., Kenessey, I., Tóvári, J., Tı́már, J., Paku, S., Kovács, G. L., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002138 · Cited by 99 · see citing works
Isung, J., Aeinehband, S., Mobarrez, F., Mårtensson, B., Nordström, P., Åsberg, M., Piehl, F., & Jokinen, J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.123 · Cited by 98 · see citing works
Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders
Lee, B.-H., & Kim, Y. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.021 · Cited by 92 · see citing works
Takebayashi, M., Hashimoto, R., Hisaoka, K., Okada‐Tsuchioka, M., & Kunugi, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0452-1 · Cited by 85 · see citing works
Viikki, M., Anttila, S. A. K., Kampman, O., Illi, A., Huuhka, M., Setälä-Soikkeli, E., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.039 · Cited by 75 · see citing works
VEGF serum levels in depressed patients during SSRI antidepressant treatment
Ventriglia, M., Zanardini, R., Pedrini, L., Placentino, A., Nielsen, M. G., Gennarelli, M., & Bocchio‐Chiavetto, L. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.009 · Cited by 69 · see citing works
Differential brain, but not serum VEGF levels in a genetic rat model of depression
Elfving, B., Plougmann, P. H., & Wegener, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.063 · Cited by 61 · see citing works
Kotan, Z., Sarandöl, E., Kırhan, E., Özkaya, G., & Kırlı, S. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312436572 · Cited by 53 · see citing works
VEGF plasma level variations in duloxetine-treated patients with major depression
Fornaro, M., Rocchi, G., Escelsior, A., Contini, P., Ghio, M., Colicchio, S., Berardis, D. D., Amore, M., Fornaro, P., & Martino, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.055 · Cited by 40 · see citing works
Tsai, S., Hong, C., Liou, Y., Chen, T., Chen, M., Hou, S.-J., Yen, F.-C., & Yu, Y. W. ‐. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.028 · Cited by 29 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142 · see citing works
Walker, W. H., Borniger, J. C., Gaudier-Diaz, M. M., Hecmarie Meléndez-Fernández, O., Pascoe, J. L., Courtney DeVries, A., & Nelson, R. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0430-4 · Cited by 129 · see citing works
Using heart rate profiles during sleep as a biomarker of depression
Saad, M., Ray, L. B., Bujaki, B., Parvaresh, A., Palamarchuk, I., De Koninck, J., Douglass, A., Lee, E. K., Soucy, L. J., Fogel, S., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2152-1 · Cited by 37 · see citing works
- Authors
- Clark-Raymond, A., Meresh, E., Hoppensteadt, D., Fareed, J., Sinacore, J., & Halaris, A.
- Affiliations
- Loyola University Chicago (US)
- Corresponding author
- Halaris, Angelos
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 59
- Pages
- 22-27
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2103499512
- Cited by
- 42
- References
- 23
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 1
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychiatric Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- vascular endothelial growth factor, major depressive disorder, diagnostic biomarkers, plasma VEGF levels, cut-off values, depression diagnosis, blood biomarkers
- MeSH terms
- Adult, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Psychiatric Status Rating Scales, Surveys and Questionnaires, Biomarkers, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
